HealthiHer

In this engaging episode of the HealthiHer podcast, Dr. Amy Brenner delves into a frequently asked question from patients: “What’s the difference between semaglutide and tirzepatide?”

With the increasing popularity of weight loss treatments, these two medications have emerged as prominent options, and understanding their distinctions can be quite valuable.

Semaglutide and tirzepatide are both notable for their role in appetite suppression and weight management, but they have unique mechanisms of action that set them apart. Dr. Brenner explains that semaglutide is a GLP-1 receptor agonist, which means it mimics a hormone that regulates appetite and glucose metabolism. It works by enhancing insulin secretion, reducing appetite, and slowing gastric emptying.

On the other hand, tirzepatide is a newer medication that targets both GLP-1 and GIP (gastric inhibitory polypeptide) receptors. This dual-action approach not only helps with appetite control but also improves insulin sensitivity more effectively.

Listeners will gain insight into how these mechanisms contribute to their effectiveness and what potential side effects might arise. Dr. Brenner also highlights the practical considerations that guide healthcare providers in choosing between these options for their patients. Factors such as individual patient needs, response to treatment, and side effect profiles play a crucial role in this decision-making process.

Additionally, the episode touches on the clinical studies that compare the efficacy and safety profiles of semaglutide and tirzepatide.

By the end of the discussion, you will have a clearer understanding of the key differences between these weight loss peptides, their respective benefits, and how they may fit into various treatment plans. Whether you’re considering these options for yourself or seeking to understand more about modern weight management therapies, this episode offers valuable insights and expert opinions.

Are weight loss medications right for you? Take our 5 minute quiz: https://dramybrenner.com/semaglutide-in-mason/

like and subscribe! 

Instagram-

https://www.instagram.com/amybrennermd/

Facebook-

https://www.facebook.com/DoctorAmyBrenner

YouTube-

https://www.youtube.com/c/AmyBrennerMD

In this episode, Dr. Amy Brenner, a seasoned surgeon specializing in women’s health treatments, sits down with Denise Lyon, an expert on the innovative Acessa procedure for fibroids. Together, they delve into the complexities of fibroids, discussing their impact on women’s lives, symptoms, and treatment options.

Key Talking Points:

Understanding Fibroids: Denise Lyon explains that fibroids are benign tumors of the uterus, influenced primarily by estrogen. They can grow in different locations—inside the uterine cavity (submucosal), within the uterine wall (intramural), or outside the uterus (subserosal)—each location impacting symptoms differently.

Prevalence and Impact: Up to 77% of women may develop fibroids, often leading to heavy bleeding (menorrhagia), pressure symptoms, pain, and other discomforts affecting daily life.

Treatment Options: Dr. Amy Brenner outlines a range of treatments from conservative approaches to more invasive procedures like hysterectomy. They discuss the benefits of Acessa, a minimally invasive laparoscopic procedure designed to shrink fibroids without the need for major surgery.

Acessa Procedure Explained: Densie and Dr. Brenner detail the Acessa procedure, highlighting its use of ultrasound to target and destroy fibroid tissue with minimal disruption. They compare it favorably to other treatments in terms of recovery time, pain management, and efficacy.

Patient Considerations: The conversation covers why Acessa might be chosen over other methods, especially for patients with bulk symptoms or specific fibroid characteristics. Success and Recovery: They share data on Acessa’s success rates, reduction in bleeding, and patient satisfaction, emphasizing its long-term benefits and quicker recovery compared to traditional surgeries.

Patient Experience: Dr. Amy Brenner discusses what patients can expect post-procedure, including pain management, recovery timeline, and when they can anticipate relief from symptoms.

Join Dr. Amy Brenner and Denise Lyon as they unpack the complexities of fibroids and explore how the Acessa procedure is reshaping treatment options for women seeking relief from this common condition.

Learn about the Acessa Procedure in Cincinnati

like and subscribe! 

Instagram-

https://www.instagram.com/amybrennermd/

Facebook-

https://www.facebook.com/DoctorAmyBrenner

YouTube-

https://www.youtube.com/c/AmyBrennerMD

Special Guest – Denise Lyon

Denise Lyon is a market development specialist with Hologic, Inc., an innovative medical technology company dedicated to enhancing women’s health and wellbeing. With a biology degree from Capital University and a surgical technology degree from Cincinnati State, Denise brings nearly nine years of experience at Hologic, having served in roles ranging from surgical medical science liaison to her current position.

Before joining Hologic, Denise gained extensive experience as a surgical technologist at Good Samaritan Hospital. Her career is driven by a profound passion for women’s health, advocating for increased education, innovation, and investment in the field.